Phase 2 Study Evaluating the Safety and Efficacy of Microneedle-mediated Delivery of Doxorubicin (D-MNA) in Patients With Nodular Basal Cell Carcinoma.
Clinical trial NCT06608238 · COMPLETED
Trial details
- NCT number
- NCT06608238
- Sponsor
- SkinJect, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-03
- Primary completion
- 2026-03-05
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.